Last reviewed · How we verify

NCT07442747

Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS

Not yet recruiting NA Last updated 2 March 2026
What this trial tests

NA trial testing Exercise in Parkinson's Disease in 36 participants. Not yet recruiting.

Timeline
1 May 2026
Primary endpoint
31 December 2029
31 December 2029

Quick facts

Lead sponsorThe Cleveland Clinic
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment36
Start date1 May 2026
Primary completion31 December 2029
Estimated completion31 December 2029

Drugs / interventions tested

Conditions studied

Sponsor

The Cleveland Clinic

Who can join

18 and older, any sex, with Parkinson's Disease or Deep Brain Stimulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is focused on people with Parkinson's disease who already have deep brain stimulation devices. The goal is to understand how aerobic exercise, specifically forced vs voluntary cycling, affects movement, thinking, and brain activity in these individuals. Parkinson's disease is a progressive condition that impacts both movement and cognitive function. Previous research suggests aerobic exercise can improve PD symptoms, but the mechanisms underlying the improvement are not fully understood. This study aims to evaluate the neural (brain) mechanisms underlying exercise.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Parkinson's Disease

Currently open trials in the same condition.

Other The Cleveland Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07442747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing